case_images: PMC7302889_01
case_images: CT Abdomen showed 3.5 x 2.5 cm primary tumour in pancreatic head/uncinate process mass with complete encasement of superior mesenteric artery (SMA)/superior mesenteric vein (SMV). No evidence of any regional lymphadenopathy or liver metastasis. The figure illustrates the approximate extent of pancreatic mass (circled), pancreatic duct dilatation (yellow arrow) and the narrow superior mesenteric artery (red arrow).
case_images: can-14-1053fig1.jpg
case_images: PMC7302889_01_can-14-1053fig1.jpg
case_images: figure1
case_images: A CT scan of the abdomen reported a newly-found pancreatic mass in the pancreatic head/uncinated process (Figure 1), about 3.5 x 2.5 cm in size and encasing the superior mesenteric artery and occluding the superior mesenteric vein near the splenoportal confluence.
case_images: CT Abdomen showing severe anasarca and retroperitoneal haemorrhage. The figure shows the bilateral retroperitoneal haemorrhages both right sided (thick arrow) and left sided (thin arrow). It illustrates the asymmetry with right side retroperitoneal haemorrhage being larger in size.
case_images: can-14-1053fig2.jpg
case_images: PMC7302889_01_can-14-1053fig2.jpg
case_images: figure2
case_images: Upon imaging, he was found to have a newly-developed retroperitoneal bleed (Figure 2).
case_images: Increasing factor VIII level as chemotherapy was given, also shows timeline of other used immunosuppressive therapies.
case_images: can-14-1053fig3.jpg
case_images: PMC7302889_01_can-14-1053fig3.jpg
case_images: figure3
case_images: Factor VIII level started to increase as the chemotherapy was started (along with Rituximab infusions and high-dose steroids which were also given), and it reached to the value of 50% by the time patient received his second cycle of chemotherapy using the Gemcitabine and nab-Paclitaxel regimen (Figure 3).